GFO Kliniken Troisdorf, Betriebsstaette St. Johannes

The medical center is at the forefront of research in stroke prevention and management, focusing on innovative therapies to reduce the risk of recurrent strokes in patients who have experienced an acute ischemic stroke or a high-risk transient ischemic attack (TIA).

• Development of novel anticoagulant therapies
• Integration of antiplatelet therapy in stroke management
• Evaluation of bleeding risks associated with stroke treatments

Through rigorous clinical trials, the center is advancing the understanding of how to effectively prevent ischemic strokes while minimizing adverse effects, thereby improving patient outcomes and quality of life.